Skip to content
The Policy VaultThe Policy Vault

lenalidomide — Medica

Follicular lymphoma

Initial criteria

  • age ≥ 18 years
  • Lenalidomide used in combination with rituximab OR in combination with Gazyva (obinutuzumab) OR patient has tried at least one other regimen

Approval duration

1 year